International Study to Predict Optimised Treatment - in Depression
Public ClinicalTrials.gov record NCT00693849. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The aim of this study is to identify genetic, physical (brain) and psychological (cognitive) markers (or combinations of them) that predict specific response to a range of antidepressants treatment (Escitalopram, Venlafaxine, Sertraline) in patients diagnosed with major depressive disorder. This study is focused on outcomes which may impact on how "personalised medicine" is implemented in depression.
Study identification
- NCT ID
- NCT00693849
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 2,688 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2008 (Type not available)
- Primary completion
- Dec 2019 (Estimated)
- Completion
- Dec 2019 (Estimated)
- Last update posted
- Jul 11, 2018
2008 – 2019
United States locations
- U.S. sites
- 13
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Shanti Clinical Trials | Colton | California | 92324 | — |
| A.D.D. Treatment Center | Mission Viejo | California | 92691 | — |
| Stanford University | Stanford | California | 94305 | — |
| Veteran Affairs/Stanford University | Stanford | California | 94305 | — |
| Center for Healing the Human Spirit | Tarzana | California | 91356 | — |
| University of Miami | Miami | Florida | 33136 | — |
| University of Missouri - St. Louis | St Louis | Missouri | 63121 | — |
| Brain Resource Center | Englewood Cliffs | New Jersey | 07632 | — |
| Brain Resource Center | New York | New York | 10023 | — |
| Weill Cornell Medical College | White Plains | New York | 10605 | — |
| Skyland Behavioral Health Associates , P.A. | Asheville | North Carolina | 28801 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| NeuroDevelopment Center | Providence | Rhode Island | 02903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00693849, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 11, 2018 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00693849 live on ClinicalTrials.gov.